相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis
Edward Fox et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
Hana Storkanova et al.
SCIENTIFIC REPORTS (2021)
Generation and functional characterization of a single-chain variable fragment (scFv) of the anti-FGF2 3F12E7 monoclonal antibody
Rodrigo Barbosa de Aguiar et al.
SCIENTIFIC REPORTS (2021)
The Type II Anti-CD20 Antibody Obinutuzumab (GA101) Is More Effective Than Rituximab at Depleting B Cells and Treating Disease in a Murine Lupus Model
Anthony D. Marinov et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Development of a novel, fully human, anti-PCSK9 antibody with potent hypolipidemic activity by utilizing phage display-based strategy
Menglong Xu et al.
EBIOMEDICINE (2021)
Solubility assessment of single-chain antibody fragment against epithelial cell adhesion molecule extracellular domain in four Escherichia coli strains
Fatemeh Sadat Javadian et al.
JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY (2021)
Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study
Matthew S. Davids et al.
CLINICAL CANCER RESEARCH (2020)
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab
Lionel Rouge et al.
SCIENCE (2020)
Development of ELISA and Lateral Flow Immunoassays for Ochratoxins (OTA and OTB) Detection Based on Monoclonal Antibody
Mohamed Hassan Fadlalla et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Epcoritamab (GEN3013; DuoBody-CD3×CD20) to induce complete response in patients with relapsed/refractory B-cell non-Hodgkin lymphoma (B-NHL): Complete dose escalation data and efficacy results from a phase I/II trial.
Martin Hutchings et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Evolution ofEscherichia coliExpression System in Producing Antibody Recombinant Fragments
Annamaria Sandomenico et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Solubility, Stability, and Avidity of Recombinant Antibody Fragments Expressed in Microorganisms
Tae Hyun Kang et al.
FRONTIERS IN MICROBIOLOGY (2020)
Mechanistic insights into bacterial metabolic reprogramming from omics-integrated genome-scale models
Noushin Hadadi et al.
NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2020)
AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma
John P. Leonard et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Analysis of the B cell receptor repertoire in six immune-mediated diseases
R. J. M. Bashford-Rogers et al.
NATURE (2019)
CD20 Targeted CAR-T for High-Risk B-Cell Non-Hodgkin Lymphomas
Mazyar Shadman et al.
BLOOD (2019)
Biochemical and biophysical characterization of purified native CD20 alone and in complex with rituximab and obinutuzumab
Morgane Agez et al.
SCIENTIFIC REPORTS (2019)
The applications of anti-CD20 antibodies to treat various B cells disorders
Zahra Payandeh et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
B-Cell Therapy for Multiple Sclerosis: Entering an Era
Ariele L. Greenfield et al.
ANNALS OF NEUROLOGY (2018)
The identification of a novel antibody for CD133 using human antibody phage display
Paige M. Glumac et al.
PROSTATE (2018)
Phage display selection of fully human antibody fragments to inhibit growth-promoting effects of glycine-extended gastrin 17 on human colorectal cancer cells
Shirin Khajeh et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Safety and efficacy of anti-CD20 immunotoxin MT-3724 in relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) in a phase I study.
Michelle A. Fanale et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Anti-CD20 monoclonal antibodies: reviewing a revolution
J. M. L. Casan et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Rituximab (anti-CD20)-modified AZD-2014-encapsulated nanoparticles killing of B lymphoma cells
Xiaolong Tang et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Oligo-clonal nanobodies as an innovative targeting agent for cancer therapy: New biology and novel targeting systems
Shahryar Khoshtinat Nikkhoi et al.
PROTEIN EXPRESSION AND PURIFICATION (2017)
Current strategies for protein production and purification enabling membrane protein structural biology
Aditya Pandey et al.
BIOCHEMISTRY AND CELL BIOLOGY (2016)
Response to: Monoclonal antibodies targeting CD20
Christian Klein et al.
MABS (2013)
Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties
Christian Klein et al.
MABS (2013)
A murine monoclonal antibody directed against the carboxyl-terminal domain of GRP78 suppresses melanoma growth in mice
Gustaaf G. de Ridder et al.
MELANOMA RESEARCH (2012)
GalaxyWEB server for protein structure prediction and refinement
Junsu Ko et al.
NUCLEIC ACIDS RESEARCH (2012)
Production of disulfide-bonded proteins in Escherichia coli
Mehmet Berkmen
PROTEIN EXPRESSION AND PURIFICATION (2012)
Progress in phage display: evolution of the technique and its applications
Tomaz Bratkovic
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
An Improved Bicistronic CD20/tCD34 Vector for Efficient Purification and In Vivo Depletion of Gene-Modified T Cells for Adoptive Immunotherapy
Isabel Vogler et al.
MOLECULAR THERAPY (2010)
Chromato-panning: an efficient new mode of identifying suitable ligands from phage display libraries
Wim Noppe et al.
BMC BIOTECHNOLOGY (2009)
A compact phage display human scFv library for selection of antibodies to a wide variety of antigens
Potjamas Pansri et al.
BMC BIOTECHNOLOGY (2009)
CD20 homo-oligomers physically associate with the B cell antigen receptor - Dissociation upon receptor engagement and recruitment of phosphoproteins and calmodulin-binding proteins
Maria J. Polyak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis
Xavier Brochet et al.
NUCLEIC ACIDS RESEARCH (2008)
Solubility of disulfide-bonded proteins in the cytoplasm of Escherichia coli and its oxidizing mutant
Sheng Xiong et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
ClusPro: a fully automated algorithm for protein-protein docking
SR Comeau et al.
NUCLEIC ACIDS RESEARCH (2004)
Colocalization of the B cell receptor and CD20 followed by activation-dependent dissociation in distinct lipid rafts
RJ Petrie et al.
JOURNAL OF IMMUNOLOGY (2002)
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
RA Clynes et al.
NATURE MEDICINE (2000)
分享论文
